Fisioloxía e farmacoloxía das enfermedades crónicas
FIFAEC
University of Oxford
Oxford, Reino UnidoPublicacións en colaboración con investigadores/as de University of Oxford (3)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2019
-
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
EBioMedicine, Vol. 43, pp. 537-552
2014
-
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
Human Molecular Genetics, Vol. 23, Núm. 4, pp. 855-869